HD

Hetalben Dipakbhai Bhadiyadara

Active Director Director DIN 07191543
DIN 07191543 First appointment Jun 2015 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Hetalben Dipakbhai Bhadiyadara

Data last updated:

Hetalben Dipakbhai Bhadiyadara is a Director at Lupitas Pharmaceuticals Private Limited (since 2015). The company operates in Pharma.

DIN 07191543
Primary Designation Director
Industry Pharma
First Appointment 12 Jun 2015
Oldest Company Age 12 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Jun 20152014Active

Directorship timeline

Open interactive timeline →
Lupitas Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Hetalben Dipakbhai Bhadiyadara

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hetalben Dipakbhai Bhadiyadara

Hetalben Dipakbhai Bhadiyadara currently holds 1 directorship: Lupitas Pharmaceuticals Private Limited (Director, since 12 Jun 2015).

Hetalben Dipakbhai Bhadiyadara was first appointed on 12 Jun 2015 as Director at Lupitas Pharmaceuticals Private Limited.

The current boards of Hetalben Dipakbhai Bhadiyadara's companies include Ashish Rameshchandra Pandya (Lupitas Pharmaceuticals Private Limited), Bhanuben Pravinbhai Vekariya (Lupitas Pharmaceuticals Private Limited), Ghanshyam Parsottambhai Laheri (Lupitas Pharmaceuticals Private Limited), Kishorkumar Maganbhai Kachhadiya (Lupitas Pharmaceuticals Private Limited), Pareshkumar Ramjibhai Dhameliya (Lupitas Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available